| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.094 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |